Latest News and Press Releases
Want to stay updated on the latest news?
-
AUSTIN, Texas, March 8, 2013 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that a cost analysis entitled, "Predicting Long-Term Costs of Heart Valve Replacement: A...
-
AUSTIN, Texas, Feb. 26, 2013 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it has received approval from the US Food & Drug Administration (FDA) to market the...
-
LOS ANGELES, Jan. 27, 2013 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today the availability of its newest product for heart valve repair and replacement at the...
-
AUSTIN, Texas, Oct. 29, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is launching two new heart valve products, the On-X® Aortic Prosthetic Valve...
-
If approval is received, the On-X valve will become the first aortic valve that allows patients to be maintained at levels of anticoagulation below currently recommended professional society...
-
AUSTIN, Texas, July 25, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it has produced a 14-minute Patient Education Video to provide prospective heart...
-
AUSTIN, Texas, May 23, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that results from a study comparing the On-X mechanical heart valve to tissue valves...
-
On-X Life Technologies Releases Expected Timelines for Reduced Anticoagulation Study Results at AATS
SAN FRANCISCO, April 30, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is releasing the expected timelines for the initial submission to the FDA of...
-
AUSTIN, Texas, Jan. 24, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is highlighting the interim results of the potentially game-changing PROACT...
-
AUSTIN, Texas, Oct. 3, 2011 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is highlighting two clinical studies completed during the first 15 years of the...